Support for the energy it takes to feel like yourself.

NAD+ stands for nicotinamide adenine dinucleotide. It is a molecule naturally found in the body and involved in cellular energy metabolism and other biological processes.

No. NAD+ is a coenzyme the body produces using nutrients, including forms of vitamin B3. Supplements such as nicotinamide riboside and nicotinamide mononucleotide are NAD+ precursors, but they are not the same as direct IV NAD+.

No. NAD+ IV therapy is not FDA-approved to treat a specific medical, psychiatric, wellness, or anti-aging condition. Injectable products are commonly compounded, and compounded drugs are not reviewed by the FDA for safety, effectiveness, and quality before marketing in the same way as approved medications.

Research has confirmed that NAD+ is biologically important, but clinical evidence supporting IV NAD+ for general wellness, fatigue, anti-aging, psychiatric conditions, or substance-use recovery is limited. Larger randomized clinical trials are still needed.

Some people report subjective changes in energy or well-being, but this response is not guaranteed and has not been conclusively established in high-quality trials of IV NAD+.

Persistent fatigue should be evaluated rather than automatically attributed to low NAD+.

IV NAD+ is not an established treatment for depression or anxiety. Individuals experiencing these symptoms should receive an appropriate behavioral health assessment and discuss evidence-based treatment options.

Yes. Some people experience nausea, abdominal discomfort, headache, chest pressure, increased heart rate, flushing, or other temporary symptoms during administration. The infusion can be slowed, paused, or stopped when needed.

Coverage varies. Our team will explain expected costs and available payment options before treatment is scheduled.

NAD+ IV infusion time varies depending on the prescribed amount, the infusion protocol, and how comfortably your body tolerates the treatment. Some infusions may be completed in approximately 90 minutes, while others may require several hours. Because NAD+ can be uncomfortable when administered too quickly, your clinical team may slow or temporarily pause the infusion. We recommend keeping the remainder of your schedule flexible, particularly for your first appointment.

Before your appointment, follow any instructions provided by the Altium Health medical team. Unless you are told otherwise, arrive well hydrated and consider eating a light meal beforehand. Wear comfortable clothing and bring something relaxing to read, watch, or listen to during the infusion.

Please provide a complete list of your medications, supplements, allergies, and medical conditions before treatment. Do not stop or change a prescribed medication unless the prescribing provider specifically instructs you to do so.

Some people experience discomfort during an NAD+ infusion, particularly when it is administered too quickly. Reported symptoms have included:

• Nausea or vomiting

• Abdominal discomfort or cramping

• Diarrhea

• Headache or lightheadedness

• Flushing or feeling warm

• Increased heart rate

• Chest or throat pressure

• Temporary fatigue

• Bruising, tenderness, or irritation at the IV site

Tell the clinical team immediately if you experience discomfort. The infusion can often be slowed or paused while your symptoms are assessed. Chest pain, difficulty breathing, swelling, severe shaking or chills, or other significant symptoms require prompt medical evaluation.

NAD+ may be difficult to tolerate when infused too quickly. If you experience nausea, cramping, chest pressure, an increased heart rate, or other discomfort, the clinical team may slow or pause the infusion.

Adjusting the rate does not mean that something has necessarily gone wrong. It allows the team to respond to your experience and prioritize comfort and safety. Because each person tolerates NAD+ differently, infusion times can vary significantly between patients and appointments.

Who may not be an appropriate candidate?

There is not currently a universally accepted, FDA-approved list of contraindications for NAD+ IV therapy. A medical evaluation is therefore important before treatment.

NAD+ IV therapy may not be appropriate—or may require additional medical clearance—for individuals who:

• Are pregnant, planning pregnancy, or breastfeeding

• Have significant or uncontrolled heart, kidney, or liver disease

• Have a medical condition requiring fluid restriction

• Are experiencing an acute illness, fever, or active infection

• Have a known allergy to any ingredient in the infusion

• Have previously experienced a serious reaction to an IV infusion

• Have medications or medical conditions that require additional monitoring

Eligibility is determined individually after reviewing your health history, medications, current symptoms, and treatment goals.

There is no standardized, evidence-based number of NAD+ infusions that is appropriate for every person. Recommendations vary depending on the individual’s goals, medical history, response, tolerance, and the reason treatment is being considered.

Some people pursue a single infusion, while others complete a short series followed by periodic reassessment. Altium Health does not recommend an automatic treatment package without first evaluating whether continued treatment remains appropriate. Results are not guaranteed, and additional infusions should be based on your response rather than a predetermined promise.

Formal research on interactions between IV NAD+ and prescription medications remains limited. Before treatment, provide the medical team with a complete list of:

• Prescription and over-the-counter medications

• Vitamins and nutritional supplements

• Herbal products

• Allergies

• Current and past medical conditions

• Previous reactions to medications or infusions

Certain medications, cardiovascular conditions, kidney or liver concerns, pregnancy, fluid restrictions, or other health factors may affect whether treatment is appropriate. Never stop or change a medication in preparation for NAD+ therapy unless directed by the prescribing provider.

NAD+ IV products are generally compounded rather than manufactured as FDA-approved medications. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality before they are marketed.

Altium Health can provide information about where its NAD+ product is prepared, how it is transported and stored, the standards followed by the compounding source, and how the infusion is prepared and administered. NAD+ intended for intravenous use should be sourced and handled specifically for sterile medical administration—not simply labeled as food-grade or supplement-grade.

Patient safety, appropriate sourcing, sterile preparation, storage, and clinical monitoring should remain central throughout the process.